The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.

Yilmaz, M; Karakoc, A; Toruner, FÜSUN; Cakir, N; Tiras, B; Ayvaz, G; Arslan, M

doi:10.1080/09513590500231627

The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.

Yilmaz M., Karakoc A., Toruner F. S., Cakir N., Tiras B., Ayvaz G., ...Daha Fazla

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, cilt.21, sa.3, ss.154-60, 2005 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 3
Basım Tarihi: 2005
Doi Numarası: 10.1080/09513590500231627
Dergi Adı: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.154-60
Anahtar Kelimeler: polycystic ovary syndrome, menstrual cyclicity, hirsutism, metformin, rosiglitazone, INSULIN-RESISTANCE, CLOMIPHENE CITRATE, OBESE WOMEN, DOUBLE-BLIND, INDUCED OVULATION, THERAPY IMPROVES, HORMONE-BINDING, HYPERANDROGENISM, ENDOCRINE, GROWTH
Gazi Üniversitesi Adresli: Evet

Özet

Objective. The aim of the present study was to assess the effects of metformin and rosiglitazone on menstrual cyclicity and hirsutism in patients with polycystic ovary syndrome (PCOS).